药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metocurine
Evogliptin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Evogliptin.
Metocurine
Anagliptin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Anagliptin.
Metocurine
Gemigliptin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Gemigliptin.
Metocurine
Carmegliptin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Carmegliptin.
Metocurine
Omarigliptin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Omarigliptin.
Metocurine
Teneligliptin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Teneligliptin.
Metocurine
2,4-thiazolidinedione
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with 2,4-thiazolidinedione.
Metocurine
Tofogliflozin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Tofogliflozin.
Metocurine
Allicin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Allicin.
Metocurine
Dutogliptin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Dutogliptin.
Metocurine
Ipragliflozin
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Ipragliflozin.
Metocurine
Insulin tregopil
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Insulin tregopil.
Metocurine
Insulin peglispro
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Insulin peglispro.
Metocurine
Insulin degludec
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Insulin degludec.
Metocurine
Insulin beef
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Insulin beef.
Metocurine
Lixisenatide
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Lixisenatide.
Metocurine
Ciglitazone
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Ciglitazone.
Metocurine
Rivoglitazone
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Rivoglitazone.
Metocurine
Netoglitazone
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Netoglitazone.
Metocurine
Lobeglitazone
The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Lobeglitazone.